Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.32% | 27.67% | 55.71% | 56.80% | -53.95% |
| Total Depreciation and Amortization | -4.49% | -2.16% | -1.17% | -3.58% | 4.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.96% | 104.63% | -14.68% | -11.86% | 5.01% |
| Change in Net Operating Assets | -- | -- | -4,305.23% | -4,203.33% | -- |
| Cash from Operations | 126.79% | 127.41% | -70.82% | -66.60% | -142.03% |
| Capital Expenditure | -60.00% | -60.00% | 71.43% | 72.15% | 88.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -60.00% | -60.00% | 71.43% | 72.15% | 88.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 30.66% | 30.66% | -24.12% | -24.12% | -9.84% |
| Issuance of Common Stock | 22.36% | 22.36% | -- | -- | 1,007.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.75% | -16.75% | -- | -- | -- |
| Cash from Financing | 22.85% | 25.72% | 21,020.30% | 20,516.18% | 989.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 345.28% | 355.68% | 66.89% | 67.71% | 258.25% |